Global /India /Healthcare /Drug Manufacturers - General /NOVARTIND

Novartis India Ltd.

NOVARTIND

• NSE: NOVARTIND • Delayed

1,030.50INR -0.3%

10.91 USD

As of 20 June 2026, Novartis India Ltd. has a market cap of $270.52M USD, ranking #19217 globally and #1080 in India. It ranks #1727 in the Healthcare sector, and #631 in the Drug Manufacturers - General industry.

Global Rank

19217

Country Rank

1080

Sector Rank

1727

Industry Rank

631

Key Stats

Market Cap

$270.52MUSD

25.53B INR

Enterprise Value

$205.47MUSD

19.4B INR

Revenue (TTM)

$36.83MUSD

3.48B INR

EBITDA (TTM)

$9.63MUSD

909.08M INR

Net Income (TTM)

$10.3MUSD

972.3M INR

EBITDA Margin

26%

Profit Margin

28%

PE Ratio

26.3

PS Ratio

7.3

PB Ratio

3.3

EV/EBITDA

20.9

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

Founded

1947

Website

novartis.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	4.6%	14%	101%	101%	40%	101%	67%	59%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	NOVARTIND Novartis India Ltd ISIN: INE234A01025 Shares Out.: Shares Outstanding: 24.691M¹ Shares Float: 6.695M² TV: TradingView: NSE: NOVARTIND SA: Stock Analysis: NSE: NOVARTIND YF: Yahoo Finance: NOVARTIND.NS GF: Google Finance: NSE: NOVARTIND BA: Barron's: NOVARTIND MS: Morningstar: XNSE: NOVARTIND	1,030.50 INR	TV: TradingView: NSE: NOVARTIND SA: Stock Analysis: NSE: NOVARTIND YF: Yahoo Finance: NOVARTIND.NS GF: Google Finance: NSE: NOVARTIND BA: Barron's: NOVARTIND MS: Morningstar: XNSE: NOVARTIND
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	500672 (NOVARTIND) Novartis India Ltd ISIN: INE234A01025 TV: TradingView: BSE: NOVARTIND SA: Stock Analysis: BOM: 500672 YF: Yahoo Finance: 500672.BO GF: Google Finance: BOM: 500672 BA: Barron's: 500672 MS: Morningstar: XBOM: 500672	1,034.10 INR	TV: TradingView: BSE: NOVARTIND SA: Stock Analysis: BOM: 500672 YF: Yahoo Finance: 500672.BO GF: Google Finance: BOM: 500672 BA: Barron's: 500672 MS: Morningstar: XBOM: 500672

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Novartis India Ltd.

Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited operates as a subsidiary of Novartis AG.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 17K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 7K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 6K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 4K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 4K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 3K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 281K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 202K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 133K%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 118K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 105K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 101K%	15.1	United States

chevron_leftBack